Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation

Objective — Previous studies have shown that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) could reverse structural and electrical atria remodeling and decrease atrial fibrillation (AF) onset or recurrence.The aim of this retrospective study was to investigate whether ACEIs/ARBs had beneficial effects on ablation outcome of chronic persistent AF. Methods and results — This study included 139patients with chronic persistent AF who underwent radiofrequency ablation in our centre. Patients were divided into an ACEIs/ARBs group or a non-ACEIs/ARBs group. During follow-up (14.6±8.9months) after AF ablation, AF-free survival in the ACEIs/ARBs group was not significantly different from the non-ACEIs/ARBs group (P=0.339). Univariate analysis showed that predictors for AF-free survival were AF history (HR, 1.064; 95% CI, 1.021-1.108; P=0.003) and duration of chronic persistent AF (HR, 1.012; 95% CI, 1.005-1.019; P=0.001). Multivariate analysis showed that predictors for AF-free survival were AF history (HR, 1.051; 95% CI, 1.004-1.101; P=0.035) and duration of chronic persistent AF (HR, 1.012; 95%CI, 1.004-1.020; P=0.004).ACEIs/ARBs therapy was not a predictor for AF-free survival neither in univariate nor multivariate analysis. Conclusion — In this observational study, no effect of ACEIs or ARBs was seen on the AF recurrence after ablation of chronic persistent AF.ACEIs/ARBs did not help to predict a better ablation outcome. Predictors for ablation outcome are AF history and duration of chronic persistent AF.

[1]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[2]  L. Lo,et al.  Progressive Remodeling of the Atrial Substrate—A Novel Finding from Consecutive Voltage Mapping in Patients with Recurrence of Atrial Fibrillation After Catheter Ablation , 2007, Journal of cardiovascular electrophysiology.

[3]  Xiao-hui Liu,et al.  Is circumferential pulmonary vein isolation preferable to stepwise segmental pulmonary vein isolation for patients with paroxysmal atrial fibrillation? , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[4]  A. Alsheikh-Ali,et al.  The Renin‐Angiotensin System: A Therapeutic Target in Atrial Fibrillation , 2006, Pacing and clinical electrophysiology : PACE.

[5]  Jun Dong,et al.  Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. , 2006, European heart journal.

[6]  F. Mohr,et al.  ACE–inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation , 2006, Basic Research in Cardiology.

[7]  J. Vijgen,et al.  Atrial fibrillation in hypertrophic cardiomyopathy: another indication for circumferential pulmonary vein ablation? , 2006, Acta cardiologica.

[8]  S. Hohnloser,et al.  Drug therapy , 2022 .

[9]  H. Heidbüchel,et al.  Long-term symptomatic benefit after radiofrequency catheter ablation for atrial flutter despite a high incidence of post-procedural atrial fibrillation , 2006, Acta cardiologica.

[10]  A. De Simone,et al.  Long‐Term Outcome of Right and Left Atrial Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation , 2006, Pacing and clinical electrophysiology : PACE.

[11]  Michel Haïssaguerre,et al.  Reverse Remodeling of the Left Cardiac Chambers After Catheter Ablation After 1 Year in a Series of Patients With Isolated Atrial Fibrillation , 2005, Circulation.

[12]  Y. Miyauchi,et al.  Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[13]  Wen-Chung Yu,et al.  Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. , 2003, European heart journal.

[14]  G. Hindricks,et al.  Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. , 2003, Journal of the American College of Cardiology.

[15]  E. Bernal,et al.  Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.

[16]  A. Goette,et al.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[17]  L. Køber,et al.  Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. , 1999, Circulation.

[18]  S. Lévy,et al.  Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.

[19]  B. Lindsay,et al.  Histopathological Study Following Catheter Guided Radiofrequency Current Ablation of the Slow Pathway in a Patient with Atrioventricular Nodal Reentrant Tachycardia , 1994, Pacing and clinical electrophysiology : PACE.

[20]  P. Lercher,et al.  Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. , 2007, American heart journal.

[21]  S. Landas,et al.  Post-mortem observations of a recent radiofrequency catheter ablation site. , 1992, The American journal of cardiovascular pathology.